These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28858851)

  • 1. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
    Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
    Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKM2 promotes glioma progression by mediating CTNNB1 expression.
    Ma C; Feng Y; Zhong K; Wei J
    Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
    Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
    Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
    Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
    Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
    Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
    Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D
    Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
    Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
    Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M; Zhao X; Yuan X; Jiang J; Li P
    Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
    Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
    Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-β-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.
    Gowda P; Patrick S; Singh A; Sheikh T; Sen E
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
    Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
    Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
    Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
    Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
    Zhang H; Feng C; Zhang M; Zeng A; Si L; Yu N; Bai M
    J Cell Biochem; 2019 Mar; 120(3):2964-2972. PubMed ID: 30500994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.